Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia - Mowitz, M E; Mangili, A; Han, L (Expert Rev Pharmacoecon Outcomes Res, 2021)